Archives

by in
Entry Author Date Location
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More 11/08/13 Boston
Karyopharm Prices Upsized IPO at $16 Per Share, Begins Trading Today 11/06/13 Boston
Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug 10/07/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
East Coast Life Sciences Roundup: Regeneron, Actavis, NPS, & More 05/24/13 Boston
Karyopharm Grabs $48.2M Series B to Advance Cancer Drugs 05/20/13 Boston
Karyopharm Therapeutics Secures $48,200,000 Series B Round 05/20/13 Boston
Karyopharm Therapeutics Secures $20,500,000 New Financing 05/02/13 Boston
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
$20M Series A For Karyopharm to Fight Cancer 11/03/10 Boston
Karyopharm Therapeutics Garners $20,000,000 Series A Financing 11/03/10 Boston
Page 1 of 1